Top

European Archives of Psychiatry and Clinical Neuroscience

Published in:

01-09-2009 | Short Communication

Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations

Authors: Robert Perneczky, Corina Pohl, Susanne Bornschein, Hans Förstl, Alexander Kurz, Janine Diehl-Schmid

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 6/2009

Abstract

Education seems to protect against symptoms of neurodegeneration, but highly educated individuals experience faster cognitive decline after the onset of dementia. No studies on the effects of education on the clinical course in frontotemporal lobar degenerations (FTLD) exist. The aim of the study was to explore the effect of education on the rate of clinical deterioration in patients with FTLD. Thirty-five patients with FTLD were recruited and followed up for 20 months in average. A correlation was calculated between years of education and monthly rate of change on the clinical dementia rating scale sum of the boxes (CDR-SOB). A linear regression analysis with the CDR-SOB monthly rate of change as dependent, and the educational years and other variables possibly associated with the rate of clinical decline as independent variables was performed. There was a significant positive association between education and CDR-SOB monthly rate of change, indicating a faster decline in the well-educated. Education was the only significant predictor of clinical deterioration.

Anneser JM, Jox RJ, Borasio GD (2007) Inappropriate sexual behaviour in a case of ALS and FTD: successful treatment with sertraline. Amyotroph Lateral Scler 8:189–190PubMedCrossRef

Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL (2003) Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60:1909–1915PubMed

Borroni B, Grassi M, Agosti C, Premi E, Archetti S, Alberici A, Bellelli G, Caimi L, Di Luca M, Padovani A (2008) Establishing short-term prognosis in frontotemporal lobar degeneration spectrum: role of genetic background and clinical phenotype. Neurobiol Aging

Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM (2003) Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 60:1005–1011PubMed

Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314PubMed

Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ (2004) Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl) 172:400–408CrossRef

Diehl-Schmid J, Forstl H, Perneczky R, Pohl C, Kurz A (2008) A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry 23:754–759PubMedCrossRef

Diehl-Schmid J, Pohl C, Perneczky R, Forstl H, Kurz A (2006) Behavioral disturbances in the course of frontotemporal dementia. Dement Geriatr Cogn Disord 22:352–357PubMedCrossRef

Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626PubMed

10.

Fellgiebel A, Muller MJ, Hiemke C, Bartenstein P, Schreckenberger M (2007) Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. World J Biol Psychiatry 8:123–126PubMedCrossRef

11.

Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef

12.

Graff-Radford NR, Ferman TJ, Lucas JA, Johnson HK, Parfitt FC, Heckman MG, Todd M, Sadowsky C, Epstein DE, Crook JE (2006) A cost effective method of identifying and recruiting persons over 80 free of dementia or mild cognitive impairment. Alzheimer Dis Assoc Disord 20:101–104PubMedCrossRef

13.

Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC (1999) Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 56:713–718PubMedCrossRef

14.

Harvey RJ, Skelton-Robinson M, Rossor MN (2003) The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 74:1206–1209PubMedCrossRef

15.

Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H (1998) The Bayer activities of daily living scale. Dement Geriatr Cogn Disord 9:20–26PubMedCrossRef

16.

Kertesz A, Davidson W, Fox H (1997) Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 24:29–36PubMed

17.

Kertesz A, Morlog D, Light M, Blair M, Davidson W, Jesso S, Brashear R (2008) Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord 25:178–185PubMedCrossRef

18.

Kipps CM, Nestor PJ, Dawson CE, Mitchell J, Hodges JR (2008) Measuring progression in frontotemporal dementia: implications for therapeutic interventions. Neurology 70:2046–2052PubMedCrossRef

19.

Klempin F, Kempermann G (2007) Adult hippocampal neurogenesis and aging. Eur Arch Psychiatry Clin Neurosci 257:271–280PubMedCrossRef

20.

Kuhn HG, Cooper-Kuhn CM, Boekhoorn K, Lucassen PJ (2007) Changes in neurogenesis in dementia and Alzheimer mouse models: are they functionally relevant? Eur Arch Psychiatry Clin Neurosci 257:281–289PubMedCrossRef

21.

Lebert F, Pasquier F (1999) Trazodone in the treatment of behaviour in frontotemporal dementia. Hum Psychopharmacol Clin Exp 14:279–281CrossRef

22.

Lebert F, Stekke W, Hasenbroekx C, Pasquier F (2004) Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord 17:355–359PubMedCrossRef

23.

Mendez MF, Shapira JS, McMurtray A, Licht E (2007) Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 15:84–87PubMedCrossRef

24.

Moretti R, Torre P, Antonello RM, Cazzato G, Bava A (2003) Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol 49:13–19PubMedCrossRef

25.

Moretti R, Torre P, Antonello RM, Cazzato G, Bava A (2003) Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen 18:265–272PubMedCrossRef

26.

Moretti R, Torre P, Antonello RM, Cazzato G, Griggio S, Bava A (2003) Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer’s disease and other dementias: a 24-month follow-up of 68 patients. Am J Alzheimers Dis Other Demen 18:205–214PubMedCrossRef

27.

Mortimer JA, Snowdon DA, Markesbery WR (2003) Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol 25:671–679PubMedCrossRef

28.

Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554PubMed

29.

Ngandu T, von Strauss E, Helkala EL, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2007) Education and dementia: what lies behind the association? Neurology 69:1442–1450PubMedCrossRef

30.

Perneczky R, Diehl-Schmid J, Drzezga A, Kurz A (2007) Brain reserve capacity in frontotemporal dementia: a voxel-based 18F-FDG PET study. Eur J Nucl Med Mol Imaging 34:1082–1087PubMedCrossRef

31.

Perneczky R, Diehl-Schmid J, Pohl C, Drzezga A, Kurz A (2007) Non-fluent progressive aphasia: cerebral metabolic patterns and brain reserve. Brain Res 1133:178–185PubMedCrossRef

32.

Perneczky R, Drzezga A, Diehl-Schmid J, Schmid G, Wohlschlager A, Kars S, Grimmer T, Wagenpfeil S, Monsch A, Kurz A (2006) Schooling mediates brain reserve in Alzheimer’s disease: findings of fluoro-deoxy-glucose-positron emission tomography. J Neurol Neurosurg Psychiatry 77:1060–1063PubMedCrossRef

33.

Perneczky R, Hartmann J, Grimmer T, Drzezga A, Kurz A (2007) Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment. J Geriatr Psychiatry Neurol 20:84–88PubMedCrossRef

34.

Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A (2006) Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry 14:139–144PubMedCrossRef

35.

Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58:1615–1621PubMed

36.

Reitan R (1985) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276CrossRef

37.

Rosen HJ, Narvaez JM, Hallam B, Kramer JH, Wyss-Coray C, Gearhart R, Johnson JK, Miller BL (2004) Neuropsychological and functional measures of severity in Alzheimer disease, frontotemporal dementia, and semantic dementia. Alzheimer Dis Assoc Disord 18:202–207PubMed

38.

Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448–460PubMedCrossRef

39.

Stern Y, Albert S, Tang MX, Tsai WY (1999) Rate of memory decline in AD is related to education and occupation: cognitive reserve? Neurology 53:1942–1947PubMed

40.

Swanberg MM (2007) Memantine for behavioral disturbances in frontotemporal dementia: a case series. Alzheimer Dis Assoc Disord 21:164–166PubMedCrossRef

41.

Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB (1995) Cognitive decline in Alzheimer’s disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol A Biol Sci Med Sci 50A:M49–M55PubMed

42.

Thalmann B, Monsch A (1997) CERAD. The Consortium to Establish a Registry for Alzheimer’s Disease. Neuropsychologische Testbatterie. Memory Clinic Basel, Basel

43.

Valenzuela MJ, Sachdev P (2006) Brain reserve and cognitive decline: a non-parametric systematic review. Psychol Med 36:1–9CrossRef

Title: Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations
Authors: Robert Perneczky
Corina Pohl
Susanne Bornschein
Hans Förstl
Alexander Kurz
Janine Diehl-Schmid
Publication date: 01-09-2009
Publisher: D. Steinkopff-Verlag
Published in: European Archives of Psychiatry and Clinical Neuroscience / Issue 6/2009
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-009-0004-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2009

State-dependent microstructural white matter changes in bipolar I depression

Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

Empathy in schizophrenia: impaired resonance

Pattern of cortical activation during processing of aversive stimuli in traumatized survivors of war and torture

Diagnosis-specific effect of familial loading on verbal working memory in schizophrenia